COVID-19 diagnosis linked to more bleeding, worse outcomes in stroke treatments
COVID-19 related inflammation, endothelial dysfunction and coagulopathy may increase the bleeding risk and lower efficacy of revascularization treatments in patients with acute ischemic stroke. We aimed to evaluate the safety and outcomes of revascularization treatments in patients with acute ischemic stroke and COVID-19.
COVID-19 patients also had an unfavorable shift in the distribution of the modified Rankin score at 3 months .Patients with acute ischemic stroke and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 treated patients.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Geographic Accessibility of COVID-19 Test to Treat SitesThis cross-sectional study explores geographic disparities in antiviral access by quantifying the accessibility of COVID-19 Test to Treat sites for subpopulations by race, ethnicity, age, and rurality.
Consulte Mais informação »
Does fenofibrate improve clinical outcomes in patients with COVID-19?Does fenofibrate improve clinical outcomes in patients with COVID-19? NatMetabolism Penn udes_oficial COVID19 coronavirus covid metabolism
Consulte Mais informação »
Financial markets bet on an end to China’s “zero-covid” policyThere are some signs change may be on the way
Consulte Mais informação »
Does vitamin D reduce COVID-19 severity?A new study examined published studies for a consistent association between vitamin D levels and coronavirus disease 2019 (COVID-19) severity.
Consulte Mais informação »
Frequent mandatory COVID-19 testing may increase risky behaviorAbstract. Mandatory surveillance testing programs are popular policies aimed to control SARS-Cov-2 and may be considered for future epidemics. However, if peopl
Consulte Mais informação »